Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.08 - $73.92 $523,224 - $576,576
-7,800 Reduced 50.65%
7,600 $543,000
Q2 2024

Aug 14, 2024

SELL
$49.79 - $68.85 $1.55 Million - $2.15 Million
-31,200 Reduced 66.95%
15,400 $1.05 Million
Q1 2024

May 15, 2024

BUY
$51.15 - $56.52 $1.88 Million - $2.07 Million
36,700 Added 370.71%
46,600 $2.5 Million
Q4 2023

Feb 14, 2024

BUY
$43.79 - $55.14 $316,382 - $398,386
7,225 Added 270.09%
9,900 $527,000
Q3 2023

Nov 14, 2023

BUY
$49.1 - $62.37 $121,522 - $154,365
2,475 Added 1237.5%
2,675 $132,000
Q2 2023

Aug 14, 2023

SELL
$52.61 - $59.54 $189,396 - $214,344
-3,600 Reduced 94.74%
200 $11,000
Q1 2023

May 15, 2023

SELL
$51.83 - $79.63 $487,202 - $748,522
-9,400 Reduced 71.21%
3,800 $215,000
Q4 2022

Feb 14, 2023

BUY
$58.4 - $75.53 $402,960 - $521,157
6,900 Added 109.52%
13,200 $980,000
Q3 2022

Nov 14, 2022

BUY
$55.32 - $67.54 $110,640 - $135,080
2,000 Added 46.51%
6,300 $375,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.4B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.